RecruitingNCT07036991
A Cohort Study Comparing PCSK9 Inhibitor Plus Statin With Statin Monotherapy for Carotid Artery Stenosis
A Cohort Study Comparing PCSK9 Inhibitor Plus Statin With Statin Monotherapy for Carotid Artery Stenosis (TRIP-CAS)
Sponsor
Changhai Hospital
Enrollment
406 participants
Start Date
Sep 5, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
A multicenter cohort study
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Evolocumab (biweekly injections) + Rosuvastatin/Atorvastatin ± Ezetimibe and a drug called Rosuvastatin/Atorvastatin ± Ezetimibe for people with carotid artery stenosis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGEvolocumab (biweekly injections) + Rosuvastatin/Atorvastatin ± Ezetimibe
PCSK9 inhibitor (biweekly injections) + rosuvastatin/atorvastatin ± ezetimibe
DRUGRosuvastatin/Atorvastatin ± Ezetimibe
Rosuvastatin/atorvastatin ± ezetimibe
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07036991
Related Trials
Balloon Guide Catheter Combined With Filter Protection for Carotid Artery Stenting
NCT072478641 location
CAS for Stenosis With High-risk Features for CEA
NCT0737024616 locations
Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning
NCT058008211 location
Study on the Trans-Carotid Artery Occlusion Shunt System
NCT069245931 location
A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis
NCT070341571 location